Stock listing
ARWR Stock Price, News, Filings & Events — Arrowhead Pharmaceuticals, Inc.
Selected listing: ARWR · NASDAQ · USD · US
This page tracks Arrowhead Pharmaceuticals, Inc.'s ARWR:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARWR:NASDAQ. ARWR:NASDAQ is the stock-level entry point for investors researching Arrowhead Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Arrowhead Pharmaceuticals, Inc. is a public company traded under the ticker ARWR in the American market. The company has a market capitalization of approximately $12.06 billion. Arrowhead focuses on developing innovative medicines using its proprietary RNA-targeted technology platform.
- Ticker
- ARWR:NASDAQ
- Asset type
- Stock
- Market cap
- $9.39B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Arrowhead Pharmaceuticals, Inc. ARWR:NASDAQ stock context
This page tracks Arrowhead Pharmaceuticals, Inc.'s ARWR:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARWR:NASDAQ. ARWR:NASDAQ is the stock-level entry point for investors researching Arrowhead Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Arrowhead Pharmaceuticals, Inc. is a public company traded under the ticker ARWR in the American market. The company has a market capitalization of approximately $12.06 billion. Arrowhead focuses on developing innovative medicines using its proprietary RNA-targeted technology platform.
Latest news from Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals Announces Interim Topline Clinical Data for the First Dual-Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia
September 15, 2026
Arrowhead Pharmaceuticals to Participate in Upcoming September 2026 Investor Conferences
September 3, 2026
Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia
August 30, 2026
Arrowhead Pharmaceuticals to Present New Clinical Data at the European Society of Cardiology Congress
August 24, 2026
People Living with Familial Chylomicronaemia Syndrome (FCS) in Germany Have Access to REDEMPLO® (plozasiran) as a New Treatment Option to Reduce Triglycerides
August 17, 2026
Arrowhead Pharmaceuticals, Inc. earnings calls
Arrowhead Pharmaceuticals, Inc. (ARWR) Q3 2026 Earnings Call
August 4, 2026 · Replay with transcript and chapters
Arrowhead Pharmaceuticals, Inc. (ARWR) Q2 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 2026 Earnings Call
February 5, 2026 · Replay with transcript and chapters
Arrowhead Pharmaceuticals, Inc. (ARWR) Q4 2025 Earnings Call
November 25, 2025 · Replay with transcript and chapters
Arrowhead Pharmaceuticals, Inc. (ARWR) Q3 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Arrowhead Pharmaceuticals, Inc. (ARWR) Q2 2025 Earnings Call
May 12, 2025 · Replay with transcript and chapters
Research Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for ARWR:NASDAQ.
Arrowhead Pharmaceuticals, Inc. company profile
View the public company page for Arrowhead Pharmaceuticals, Inc. on 6ix.
Arrowhead Pharmaceuticals, Inc. news
Read company news and market updates connected to Arrowhead Pharmaceuticals, Inc..
Arrowhead Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Arrowhead Pharmaceuticals, Inc..
Alternate listings
HDP1:GETTEX
DE · EUR
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
A2RR34:BMFBOVESPA
BR · BRL
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
A2AGYB:LSX
DE · EUR
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
A2AGYB:LS
DE · EUR
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
ARWR:BMV
MX · MXN
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
0HI3:LSE
GB · USD
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
ARWR:BOATS
US · USD
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
HDP1:TRADEGATE
DE · EUR
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
HDP1:FWB
DE · EUR
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
HDP1:SWB
DE · EUR
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
ARWR:BIVA
MX · MXN
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
HDP1:BX
CH · CHF
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.